FDA
Darifenacin Hydrobromide
The FDA lists this product in 16 strengths and forms.
Composition
- Active ingredients
- DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DARIFENACIN HYDROBROMIDE EQ 15MG BASE · Tablet, extended releaseANDA211045-002 · Prescription
- DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE · Tablet, extended releaseANDA211045-001 · Prescription
- DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE · Tablet, extended releaseANDA091190-001 · Discontinued
- DARIFENACIN HYDROBROMIDE EQ 15MG BASE · Tablet, extended releaseANDA091190-002 · Discontinued
- DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE · Tablet, extended releaseANDA207664-001 · Prescription
- DARIFENACIN HYDROBROMIDE EQ 15MG BASE · Tablet, extended releaseANDA207664-002 · Prescription
- DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE · Tablet, extended releaseANDA205550-001 · Discontinued
- DARIFENACIN HYDROBROMIDE EQ 15MG BASE · Tablet, extended releaseANDA205550-002 · Discontinued
- DARIFENACIN HYDROBROMIDE EQ 7.5MG BASE · Tablet, extended releaseANDA206743-001 · Prescription
- DARIFENACIN HYDROBROMIDE EQ 15MG BASE · Tablet, extended release
At a glance
- Brand name
- Darifenacin Hydrobromide
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Xiromed
- Status
- Discontinued
- FDA approval
- 22 Oct 2019
- Application
- ANDA209571-002